Prof Andrew Scott
Honorary (Professorial Fellow)
Department of Medicine
927 Scholarly works
2 Projects
HIGHLIGHTS
2026
Journal article
Monitoring glioblastoma dynamics during chemoradiation on the 1.5 T magnetic resonance imaging-linear accelerator
DOI: 10.1016/j.ctro.2026.1012002026
Journal article
iPREDICT: Phase II study of CD8 PET in patients with immunoresponsive solid tumors—Imaging characteristics and correlation with RECIST response.
DOI: 10.1200/jco.2026.44.16_suppl.30692026
Journal article
Phase 3 study to assess the safety and efficacy of 177 Lu-girentuximab in advanced, relapsed, or recurrent ccRCC (LUTEON).
DOI: 10.1200/jco.2026.44.16_suppl.tps46312026
Journal article
Usefulness of CAIX-targeted PET in restaging clear cell renal cell carcinoma: detection of thyroid metastasis with [89Zr]Zr-girentuximab
DOI: 10.1016/j.eanmi.2026.1002662026
Journal article
Health technology assessment in nuclear medicine: Challenges and opportunities in Europe
DOI: 10.1016/j.eanmj.2026.1002152026
Research grants (ARC, NHMRC, MRFF)
Characterising the Plasma Proteome of Polymyalgia Rheumatica
2025
Research grants (ARC, NHMRC, MRFF)
Application of Molecular Imaging Biomarkers in Large Vessel Vasculitis and Polymyalgia Rheumatica
RECENT SCHOLARLY WORKS
2026
Journal article
Assessment of Lean body mass using whole-body low-dose Ct from Pet/Ct to identify cancer Cachexia.
DOI: 10.1186/s40644-026-01047-32026
Journal article
Clinical outcomes and quality of life in glioblastoma patients treated with MR-guided adaptive radiotherapy using a 1.5 T MR-Linac in an Australian setting
DOI: 10.1016/j.ctro.2026.1011322026
Journal article
Estimating global cancer survival and mortality from 1990 to 2050: a simulation-based analysis of 17 cancers
DOI: 10.1016/S1470-2045(26)00061-62026
Journal article
Estimating total and diagnosed global cancer incidence and stage distribution from 1990 to 2050: a simulation-based analysis of 17 cancers
DOI: 10.1016/S1470-2045(26)00060-42026
Journal article
Estimating the impact of scaling up workforce personnel on global cancer mortality from 2030 to 2050: a simulation-based analysis of 17 cancers and 18 personnel types
DOI: 10.1016/S1470-2045(26)00062-8